Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride and metformin both help treat PCOS, but using them together works best.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hair loss may indicate higher heart risk and metabolic issues.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.